3.23.3 html 336 398 1 true 125 0 false 7 false false R1.htm 00000001 - Document - Cover Sheet http://oncocyte.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://oncocyte.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://oncocyte.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://oncocyte.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://oncocyte.com/role/StatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Sheet http://oncocyte.com/role/StatementsOfShareholdersEquity Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://oncocyte.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Organization, Description of the Business and Liquidity Sheet http://oncocyte.com/role/OrganizationDescriptionOfBusinessAndLiquidity Organization, Description of the Business and Liquidity Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://oncocyte.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Business Combinations Sheet http://oncocyte.com/role/BusinessCombinations Business Combinations Notes 10 false false R11.htm 00000011 - Disclosure - Right-Of-Use and Financing Lease Assets, Machinery and Equipment, Net, and Construction in Progress Sheet http://oncocyte.com/role/Right-of-useAndFinancingLeaseAssetsMachineryAndEquipmentNetAndConstructionInProgress Right-Of-Use and Financing Lease Assets, Machinery and Equipment, Net, and Construction in Progress Notes 11 false false R12.htm 00000012 - Disclosure - Intangible Assets, Net Sheet http://oncocyte.com/role/IntangibleAssetsNet Intangible Assets, Net Notes 12 false false R13.htm 00000013 - Disclosure - Loan Payable to Silicon Valley Bank Sheet http://oncocyte.com/role/LoanPayableToSiliconValleyBank Loan Payable to Silicon Valley Bank Notes 13 false false R14.htm 00000014 - Disclosure - Commitments and Contingencies Sheet http://oncocyte.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 00000015 - Disclosure - Shareholders??? Equity Sheet http://oncocyte.com/role/ShareholdersEquity Shareholders??? Equity Notes 15 false false R16.htm 00000016 - Disclosure - Stock-Based Compensation Sheet http://oncocyte.com/role/Stock-basedCompensation Stock-Based Compensation Notes 16 false false R17.htm 00000017 - Disclosure - Income Taxes Sheet http://oncocyte.com/role/IncomeTaxes Income Taxes Notes 17 false false R18.htm 00000018 - Disclosure - Related Party Transactions Sheet http://oncocyte.com/role/RelatedPartyTransactions Related Party Transactions Notes 18 false false R19.htm 00000019 - Disclosure - Co-Development Agreement with Life Technologies Corporation Sheet http://oncocyte.com/role/Co-developmentAgreementWithLifeTechnologiesCorporation Co-Development Agreement with Life Technologies Corporation Notes 19 false false R20.htm 00000020 - Disclosure - Discontinued Operations of Razor Sheet http://oncocyte.com/role/DiscontinuedOperationsOfRazor Discontinued Operations of Razor Notes 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://oncocyte.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://oncocyte.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://oncocyte.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://oncocyte.com/role/SummaryOfSignificantAccountingPolicies 22 false false R23.htm 00000023 - Disclosure - Business Combinations (Tables) Sheet http://oncocyte.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://oncocyte.com/role/BusinessCombinations 23 false false R24.htm 00000024 - Disclosure - Right-Of-Use and Financing Lease Assets, Machinery and Equipment, Net, and Construction in Progress (Tables) Sheet http://oncocyte.com/role/Right-of-useAndFinancingLeaseAssetsMachineryAndEquipmentNetAndConstructionInProgressTables Right-Of-Use and Financing Lease Assets, Machinery and Equipment, Net, and Construction in Progress (Tables) Tables http://oncocyte.com/role/Right-of-useAndFinancingLeaseAssetsMachineryAndEquipmentNetAndConstructionInProgress 24 false false R25.htm 00000025 - Disclosure - Intangible Assets, Net (Tables) Sheet http://oncocyte.com/role/IntangibleAssetsNetTables Intangible Assets, Net (Tables) Tables http://oncocyte.com/role/IntangibleAssetsNet 25 false false R26.htm 00000026 - Disclosure - Commitments and Contingencies (Tables) Sheet http://oncocyte.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://oncocyte.com/role/CommitmentsAndContingencies 26 false false R27.htm 00000027 - Disclosure - Stock-Based Compensation (Tables) Sheet http://oncocyte.com/role/Stock-basedCompensationTables Stock-Based Compensation (Tables) Tables http://oncocyte.com/role/Stock-basedCompensation 27 false false R28.htm 00000028 - Disclosure - Discontinued Operations of Razor (Tables) Sheet http://oncocyte.com/role/DiscontinuedOperationsOfRazorTables Discontinued Operations of Razor (Tables) Tables http://oncocyte.com/role/DiscontinuedOperationsOfRazor 28 false false R29.htm 00000029 - Disclosure - Organization, Description of the Business and Liquidity (Details Narrative) Sheet http://oncocyte.com/role/OrganizationDescriptionOfBusinessAndLiquidityDetailsNarrative Organization, Description of the Business and Liquidity (Details Narrative) Details http://oncocyte.com/role/OrganizationDescriptionOfBusinessAndLiquidity 29 false false R30.htm 00000030 - Disclosure - Schedule of Fair Value Measurement of Financial Assets and Liabilities (Details) Sheet http://oncocyte.com/role/ScheduleOfFairValueMeasurementOfFinancialAssetsAndLiabilitiesDetails Schedule of Fair Value Measurement of Financial Assets and Liabilities (Details) Details 30 false false R31.htm 00000031 - Disclosure - Schedule of Disaggregation Of Revenue (Details) Sheet http://oncocyte.com/role/ScheduleOfDisaggregationOfRevenueDetails Schedule of Disaggregation Of Revenue (Details) Details 31 false false R32.htm 00000032 - Disclosure - Schedule of Concentration Of Risk (Details) Sheet http://oncocyte.com/role/ScheduleOfConcentrationOfRiskDetails Schedule of Concentration Of Risk (Details) Details 32 false false R33.htm 00000033 - Disclosure - Schedule of Consolidated Revenues Generated by Unaffiliated Customers (Details) Sheet http://oncocyte.com/role/ScheduleOfConsolidatedRevenuesGeneratedByUnaffiliatedCustomersDetails Schedule of Consolidated Revenues Generated by Unaffiliated Customers (Details) Details 33 false false R34.htm 00000034 - Disclosure - Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations (Details) Sheet http://oncocyte.com/role/ScheduleOfPercentageOfConsolidatedRevenuesAttributableToGeographicalLocationsDetails Schedule of Percentage of Consolidated Revenues Attributable to Geographical Locations (Details) Details 34 false false R35.htm 00000035 - Disclosure - Schedule of Common Stock Computation of Diluted Net Loss Per Share of Common Stock (Details) Sheet http://oncocyte.com/role/ScheduleOfCommonStockComputationOfDilutedNetLossPerShareOfCommonStockDetails Schedule of Common Stock Computation of Diluted Net Loss Per Share of Common Stock (Details) Details 35 false false R36.htm 00000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://oncocyte.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://oncocyte.com/role/SummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 00000037 - Disclosure - Schedule of Fair Value of Contingent Consideration Liability (Details) Sheet http://oncocyte.com/role/ScheduleOfFairValueOfContingentConsiderationLiabilityDetails Schedule of Fair Value of Contingent Consideration Liability (Details) Details 37 false false R38.htm 00000038 - Disclosure - Schedule of Contingent Consideration, Measured at Fair Value (Details) Sheet http://oncocyte.com/role/ScheduleOfContingentConsiderationMeasuredAtFairValueDetails Schedule of Contingent Consideration, Measured at Fair Value (Details) Details 38 false false R39.htm 00000039 - Disclosure - Business Combinations (Details Narrative) Sheet http://oncocyte.com/role/BusinessCombinationsDetailsNarrative Business Combinations (Details Narrative) Details http://oncocyte.com/role/BusinessCombinationsTables 39 false false R40.htm 00000040 - Disclosure - Schedule of Right-of-use Assets, Machinery and Equipment, Net, and Construction in Progress (Details) Sheet http://oncocyte.com/role/ScheduleOfRight-of-useAssetsMachineryAndEquipmentNetAndConstructionInProgressDetails Schedule of Right-of-use Assets, Machinery and Equipment, Net, and Construction in Progress (Details) Details 40 false false R41.htm 00000041 - Disclosure - Right-Of-Use and Financing Lease Assets, Machinery and Equipment, Net, and Construction in Progress (Details Narrative) Sheet http://oncocyte.com/role/Right-of-useAndFinancingLeaseAssetsMachineryAndEquipmentNetAndConstructionInProgressDetailsNarrative Right-Of-Use and Financing Lease Assets, Machinery and Equipment, Net, and Construction in Progress (Details Narrative) Details http://oncocyte.com/role/Right-of-useAndFinancingLeaseAssetsMachineryAndEquipmentNetAndConstructionInProgressTables 41 false false R42.htm 00000042 - Disclosure - Schedule of Goodwill and Intangible Assets (Details) Sheet http://oncocyte.com/role/ScheduleOfGoodwillAndIntangibleAssetsDetails Schedule of Goodwill and Intangible Assets (Details) Details 42 false false R43.htm 00000043 - Disclosure - Schedule of Intangible Assets Future Amortization Expense (Details) Sheet http://oncocyte.com/role/ScheduleOfIntangibleAssetsFutureAmortizationExpenseDetails Schedule of Intangible Assets Future Amortization Expense (Details) Details 43 false false R44.htm 00000044 - Disclosure - Intangible Assets, Net (Details Narrative) Sheet http://oncocyte.com/role/IntangibleAssetsNetDetailsNarrative Intangible Assets, Net (Details Narrative) Details http://oncocyte.com/role/IntangibleAssetsNetTables 44 false false R45.htm 00000045 - Disclosure - Loan Payable to Silicon Valley Bank (Details Narrative) Sheet http://oncocyte.com/role/LoanPayableToSiliconValleyBankDetailsNarrative Loan Payable to Silicon Valley Bank (Details Narrative) Details http://oncocyte.com/role/LoanPayableToSiliconValleyBank 45 false false R46.htm 00000046 - Disclosure - Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases (Details) Sheet http://oncocyte.com/role/ScheduleOfSupplementalBalanceSheetInformationRelatedToOperatingAndFinancingLeasesDetails Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases (Details) Details 46 false false R47.htm 00000047 - Disclosure - Schedule of Future Minimum Lease Commitments for Operating and Financing Leases (Details) Sheet http://oncocyte.com/role/ScheduleOfFutureMinimumLeaseCommitmentsForOperatingAndFinancingLeasesDetails Schedule of Future Minimum Lease Commitments for Operating and Financing Leases (Details) Details 47 false false R48.htm 00000048 - Disclosure - Schedule of Supplemental Cash Flow Information Related to Operating and Financing Lease (Details) Sheet http://oncocyte.com/role/ScheduleOfSupplementalCashFlowInformationRelatedToOperatingAndFinancingLeaseDetails Schedule of Supplemental Cash Flow Information Related to Operating and Financing Lease (Details) Details 48 false false R49.htm 00000049 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://oncocyte.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://oncocyte.com/role/CommitmentsAndContingenciesTables 49 false false R50.htm 00000050 - Disclosure - Shareholders??? Equity (Details Narrative) Sheet http://oncocyte.com/role/ShareholdersEquityDetailsNarrative Shareholders??? Equity (Details Narrative) Details http://oncocyte.com/role/ShareholdersEquity 50 false false R51.htm 00000051 - Disclosure - Summary of Stock Option Activity (Details) Sheet http://oncocyte.com/role/SummaryOfStockOptionActivityDetails Summary of Stock Option Activity (Details) Details 51 false false R52.htm 00000052 - Disclosure - Schedule of Assumptions Used to Calculate Fair Value of Stock Options (Details) Sheet http://oncocyte.com/role/ScheduleOfAssumptionsUsedToCalculateFairValueOfStockOptionsDetails Schedule of Assumptions Used to Calculate Fair Value of Stock Options (Details) Details 52 false false R53.htm 00000053 - Disclosure - Summary of Stock-based Compensation Expense (Details) Sheet http://oncocyte.com/role/SummaryOfStock-basedCompensationExpenseDetails Summary of Stock-based Compensation Expense (Details) Details 53 false false R54.htm 00000054 - Disclosure - Stock-Based Compensation (Details Narrative) Sheet http://oncocyte.com/role/Stock-basedCompensationDetailsNarrative Stock-Based Compensation (Details Narrative) Details http://oncocyte.com/role/Stock-basedCompensationTables 54 false false R55.htm 00000055 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://oncocyte.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://oncocyte.com/role/RelatedPartyTransactions 55 false false R56.htm 00000056 - Disclosure - Co-Development Agreement with Life Technologies Corporation (Details Narrative) Sheet http://oncocyte.com/role/Co-developmentAgreementWithLifeTechnologiesCorporationDetailsNarrative Co-Development Agreement with Life Technologies Corporation (Details Narrative) Details http://oncocyte.com/role/Co-developmentAgreementWithLifeTechnologiesCorporation 56 false false R57.htm 00000057 - Disclosure - Schedule of Discontinued Operations (Details) Sheet http://oncocyte.com/role/ScheduleOfDiscontinuedOperationsDetails Schedule of Discontinued Operations (Details) Details 57 false false R58.htm 00000058 - Disclosure - Schedule of Assets and Liabilities Discontinued Operations (Details) Sheet http://oncocyte.com/role/ScheduleOfAssetsAndLiabilitiesDiscontinuedOperationsDetails Schedule of Assets and Liabilities Discontinued Operations (Details) Details 58 false false R59.htm 00000059 - Disclosure - Discontinued Operations of Razor (Details Narrative) Sheet http://oncocyte.com/role/DiscontinuedOperationsOfRazorDetailsNarrative Discontinued Operations of Razor (Details Narrative) Details http://oncocyte.com/role/DiscontinuedOperationsOfRazorTables 59 false false All Reports Book All Reports form10-q.htm ocx-20230930.xsd ocx-20230930_cal.xml ocx-20230930_def.xml ocx-20230930_lab.xml ocx-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true